Omicron variant – Variant of concern

A new COVID variant "Omicron" has set foot in the world. Will the existing vaccines remain effective against it? Read on to know about the same

With the emergence of the novel coronavirus, new variants and mutations have continued to emerge, with the Delta variant proving to be the most dangerous of all.

Now, a new COVID variant "Omicron" has set foot in the world. First detected in South Africa, the B.1.1.529 variant is said to be extremely dangerous. Because of the sudden surge in the number of COVID patients in South Africa, experts believe that the new variant has a high transmissibility rate. The World Health Organization (WHO) has declared B.1.1.529 a variant of concern. The variant of concern is linked to an increase in transmissibility, more severe disease (increased hospitalizations or deaths). Although there is no data available to suggest that Omicron is more transmissible. As of now, the Delta variant continues to remain the most dominant strain of the SARs-COV-2 virus. Symptoms are common - fever, sore throat, fatigue, headache and in severe cases shortness of breath, chest pain, etc.

Omicron virus and current COVID vaccine

According to the study, the new variant Omicron has over 30 mutations in the spike protein, which helps it potentially develop an 'immune-escape mechanism'. Spike protein is the compound that enables a virus to enter the host cell and is what makes it more transmissible and infectious. Most of the COVID vaccines are developed to form antibodies against the spike protein, the multiple mutations in the spike protein make it harder for the vaccines to identify the new alterations, making it less effective.

How dangerous is omicron?

However, according to the WHO, preliminary data suggests that there may be an increased risk of reinfection with 'Omicron'. That means those who have previously had COVID-19 could become reinfected more easily with this variant.

Given that viruses are bound to mutate, the SARs-COV-2 virus is no different. As of now, there are multiple COVID variants lingering in and around the world. That said, experts believe that there may be a need to update COVID vaccines just like the influenza shots.

Apart from the vaccines, health professionals and experts advise people to remain vigilant. People should do their part of wearing a mask, maintaining social distance and practicing healthy hand hygiene.

Tags : #Health #Omicron #NewCOVIDstrain #Newvariant #COVIDvaccine #Medicircle #smitakumar

Related Stories

Loading Please wait...


Trending Now

In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024